Table 5.
Quintile ranking in function of HPV positivity and cytology after HR targeted rescreening of samples from the GS group
| Quintile | Total | ||||||
|---|---|---|---|---|---|---|---|
| ONC+RE | HPV | 1 | 2 | 3 | 4 | 5 | n |
| NEG | - | 52 | 53 | 61 | 73 | 63 | 302 |
| X+ | 37 | 50 | 59 | 55 | 57 | 258 | |
| Onc+ | 19A | 28P | 31F | 29B,L | 18 | 125 | |
| ASC-US | Onc+ | 2 | 6C,N | 4 | 2 | 4 | 18 |
| ASC-H | Onc+ | 2 | 1 O | 3 | |||
| L-SIL | Onc+ | 2M | 2D | 1 | 5 | ||
| H-SIL | Onc+ | 2E | 2 | ||||
| Total | 116 | 137 | 156 | 161 | 143 | 713 |
A-F,L-P CIN 2+ biopsy confirmed, ONC+RE = HR HPV targeted rescreening.